← Open Payments lookup

SCOTT DEWHIRST: Open Payments

NPI 1659799153 · SANTA BARBARA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,014 in 50 payments from 16 companies in 2025. Trend: 2023 $250 · 2024 $366 · 2025 $1,014

Food & beverage: $1,014
CompanyPaymentsAmount
ABBVIE INC.21$229
Brainsway USA INC1$136
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$94
Teva Pharmaceuticals USA, Inc.3$80
Axsome Therapeutics, Inc.3$64
Alkermes, Inc.2$61
Neurocrine BioSciences, Inc.2$58
E.R. Squibb & Sons, L.L.C.3$54
Janssen Pharmaceuticals, Inc2$43
Vanda Pharmaceuticals Inc.2$40

Products named: VRAYLAR, deep tms, CAPLYTA, AUSTEDO XR, INGREZZA, COBENFY, REXULTI, SPRAVATO.

Industry payments across CA — which companies pay providers there.